Ustekinumab. Análisis de efectos adversos infecciosos
Ustekinumab. Analysis of Rates of Infection
P. Herranz-Pinto
, E. Sendagorta
Corresponding author
Servicio de Dermatología. Hospital Universitario La Paz. Madrid. España
Read
4036
Timeswas read the article
2103
Total PDF
1933
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 July | 27 | 12 | 39 |
| 2024 June | 55 | 28 | 83 |
| 2024 May | 47 | 45 | 92 |
| 2024 April | 44 | 31 | 75 |
| 2024 March | 29 | 30 | 59 |
| 2024 February | 23 | 27 | 50 |
| 2024 January | 18 | 25 | 43 |
| 2023 December | 22 | 17 | 39 |
| 2023 November | 26 | 21 | 47 |
| 2023 October | 24 | 18 | 42 |
| 2023 September | 22 | 27 | 49 |
| 2023 August | 26 | 22 | 48 |
| 2023 July | 21 | 26 | 47 |
| 2023 June | 12 | 33 | 45 |
| 2023 May | 9 | 22 | 31 |
| 2023 April | 17 | 25 | 42 |
| 2023 March | 15 | 33 | 48 |
| 2023 February | 17 | 22 | 39 |
| 2023 January | 17 | 31 | 48 |
| 2022 December | 22 | 39 | 61 |
| 2022 November | 23 | 34 | 57 |
| 2022 October | 69 | 26 | 95 |
| 2022 September | 49 | 40 | 89 |
| 2022 August | 44 | 45 | 89 |
| 2022 July | 22 | 45 | 67 |
| 2022 June | 15 | 55 | 70 |
| 2022 May | 22 | 38 | 60 |
| 2022 April | 31 | 30 | 61 |
| 2022 March | 20 | 42 | 62 |
| 2022 February | 20 | 26 | 46 |
| 2022 January | 21 | 36 | 57 |
| 2021 December | 15 | 32 | 47 |
| 2021 November | 22 | 41 | 63 |
| 2021 October | 21 | 51 | 72 |
| 2021 September | 20 | 44 | 64 |
| 2021 August | 25 | 28 | 53 |
| 2021 July | 11 | 24 | 35 |
| 2021 June | 19 | 49 | 68 |
| 2021 May | 18 | 40 | 58 |
| 2021 April | 49 | 63 | 112 |
| 2021 March | 42 | 39 | 81 |
| 2021 February | 26 | 24 | 50 |
| 2021 January | 25 | 13 | 38 |
| 2020 December | 15 | 17 | 32 |
| 2020 November | 10 | 17 | 27 |
| 2020 October | 24 | 12 | 36 |
| 2020 September | 11 | 6 | 17 |
| 2020 August | 21 | 13 | 34 |
| 2020 July | 19 | 11 | 30 |
| 2020 June | 24 | 22 | 46 |
| 2020 May | 21 | 32 | 53 |
| 2020 April | 20 | 15 | 35 |
| 2020 March | 25 | 17 | 42 |
| 2020 January | 0 | 5 | 5 |
| 2019 December | 0 | 3 | 3 |
| 2019 November | 0 | 1 | 1 |
| 2019 October | 0 | 2 | 2 |
| 2019 September | 0 | 5 | 5 |
| 2019 August | 0 | 1 | 1 |
| 2019 July | 0 | 6 | 6 |
| 2019 June | 0 | 3 | 3 |
| 2019 May | 0 | 23 | 23 |
| 2019 April | 0 | 25 | 25 |
| 2019 February | 1 | 5 | 6 |
| 2019 January | 0 | 3 | 3 |
| 2018 December | 1 | 7 | 8 |
| 2018 November | 0 | 2 | 2 |
| 2018 October | 0 | 3 | 3 |
| 2018 August | 0 | 6 | 6 |
| 2018 June | 0 | 4 | 4 |
| 2018 February | 13 | 5 | 18 |
| 2018 January | 12 | 4 | 16 |
| 2017 December | 12 | 9 | 21 |
| 2017 November | 10 | 7 | 17 |
| 2017 October | 8 | 5 | 13 |
| 2017 September | 9 | 7 | 16 |
| 2017 August | 6 | 10 | 16 |
| 2017 July | 12 | 3 | 15 |
| 2017 June | 14 | 6 | 20 |
| 2017 May | 8 | 9 | 17 |
| 2017 April | 18 | 16 | 34 |
| 2017 March | 11 | 25 | 36 |
| 2017 February | 9 | 9 | 18 |
| 2017 January | 10 | 21 | 31 |
| 2016 December | 23 | 11 | 34 |
| 2016 November | 23 | 12 | 35 |
| 2016 October | 22 | 9 | 31 |
| 2016 September | 30 | 13 | 43 |
| 2016 August | 29 | 15 | 44 |
| 2016 July | 18 | 8 | 26 |
| 2016 June | 0 | 4 | 4 |
| 2016 May | 0 | 9 | 9 |
| 2016 April | 1 | 1 | 2 |
| 2016 March | 0 | 2 | 2 |
| 2016 February | 0 | 4 | 4 |
| 2016 January | 0 | 16 | 16 |
| 2015 December | 0 | 19 | 19 |
| 2015 November | 5 | 16 | 21 |
| 2015 October | 3 | 5 | 8 |
| 2015 September | 5 | 13 | 18 |
| 2015 August | 6 | 7 | 13 |
| 2015 July | 22 | 3 | 25 |
| 2015 June | 21 | 3 | 24 |
| 2015 May | 45 | 19 | 64 |
| 2015 April | 30 | 12 | 42 |
| 2015 March | 26 | 20 | 46 |
| 2015 February | 29 | 10 | 39 |
| 2015 January | 33 | 12 | 45 |
| 2014 December | 34 | 8 | 42 |
| 2014 November | 23 | 11 | 34 |
| 2014 October | 34 | 29 | 63 |
| 2014 September | 0 | 2 | 2 |
| 2014 May | 1 | 0 | 1 |
| 2014 January | 0 | 1 | 1 |
| 2013 September | 1 | 1 | 2 |
| 2013 June | 0 | 1 | 1 |
| 2013 May | 1 | 1 | 2 |
| 2013 April | 1 | 2 | 3 |
| 2013 February | 1 | 2 | 3 |
| 2013 January | 0 | 1 | 1 |
Show all
